What is Opgen's (opgn) stock price?
ROCKVILLE, Md., Jan. 18, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of …
What does opgn stand for?
Apr 06, 2022 · OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular...
Where can I buy shares of opgn?
Apr 03, 2022 · OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings.
How much of Opgen's stock is owned by insiders?
Apr 12, 2022 · Real-time trade and investing ideas on OpGen OPGN from the largest community of traders and investors.
Is OPGN a good stock to buy?
Is Opgen Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: OPGN) stock is to Strong Buy OPGN stock.
Will OPGN stock go up?
Stock Price Forecast The 2 analysts offering 12-month price forecasts for OpGen Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +381.36% increase from the last price of 0.73.
When did OPGN go public?
GAITHERSBURG, Md. , May 5, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq:OPGN) today announced the pricing of its initial public offering of 2,850,000 units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, at a combined price to the public of $6.00 per unit.
Is OPGN FDA approved?
A genetic testing product from Rockville, Maryland's OpGen is officially FDA certified. On Monday, the company said its Acuitas AMR Gene Panel was approved by the U.S. Food and Drug Administration (FDA).Oct 5, 2021
Why is OCGN stock down?
Ocugen's OCGN stock declined 3.8% on Tuesday after the FDA placed a clinical hold on a phase II/III immuno-bridging and broadening clinical study on its COVID-19 vaccine, Covaxin.3 days ago
Is OpGen a buy right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OpGen in the last twelve months. There are currently 2 b...
How has OpGen's stock price been impacted by COVID-19?
OpGen's stock was trading at $2.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then...
Are investors shorting OpGen?
OpGen saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 422,400 shares, an increase...
When is OpGen's next earnings date?
OpGen is scheduled to release its next quarterly earnings announcement on Tuesday, March 29th 2022. View our earnings forecast for OpGen .
How can I listen to OpGen's earnings call?
OpGen will be holding an earnings conference call on Tuesday, March 29th at 4:30 PM Eastern. Interested parties can register for or listen to the c...
How were OpGen's earnings last quarter?
OpGen, Inc. (NASDAQ:OPGN) released its quarterly earnings results on Thursday, November, 11th. The medical research company reported ($0.16) earnin...
When did OpGen's stock split? How did OpGen's stock split work?
OpGen's stock reverse split before market open on Friday, January 19th 2018. The 1-25 reverse split was announced on Wednesday, January 17th 2018....
What guidance has OpGen issued on next quarter's earnings?
OpGen issued an update on its fourth quarter 2021 earnings guidance on Monday, February, 7th. The company provided earnings per share guidance of f...
What price target have analysts set for OPGN?
2 brokerages have issued 12 month price targets for OpGen's shares. Their forecasts range from $3.00 to $4.00. On average, they expect OpGen's shar...
Recently Viewed Tickers
OpGen Inc
Visit a quote page and your recently viewed tickers will be displayed here.
About OpGen
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings.
OpGen (NASDAQ:OPGN) Frequently Asked Questions
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings.
About OPGN
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OpGen in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" OpGen stock. View analyst ratings for OpGen or view top-rated stocks.
Analyst Forecast
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases.
News
According to 2 analysts, the average rating for OpGen stock is "Buy." The 12-month stock price forecast is 3.50, which is an increase of 277.56% from the latest price.
OpGen (OPGN)
ROCKVILLE, Md., Feb. 10, 2022 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectiou...
OpGen, Inc. - Buy
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Style Scorecard
Zacks' proprietary data indicates that OpGen, Inc. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the OPGN shares relative to the market in the next few months. In addition, OpGen, Inc.
Chart for OPGN
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
The OPGN meeting will take place when?
OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.
Why the proposal is important for OPGN?
To combat infectious diseases, OpGen combines molecular diagnostics with bioinformatics. As a developer and manufacturer of molecular microbiology solutions, OPGN develops solutions in conjunction with subsidiaries, Curetis GmbH and Ares Genetics GmbH.
Top 3 Stocks Closing the Week on a High Note Despite Sluggish Market Sentiment
With its strong cash position of $39.4 million at the end of the second quarter of 2021, these additional authorized shares will provide OpGen (OPGN) with the additional flexibility to seek future funding in order to continue expanding, strategically managing and possibly helping to reduce its long-term debt, and raising additional capital when needed.
